Mechanisms of NK Cell Activation and Clinical Activity of the Therapeutic SLAMF7 Antibody, Elotuzumab in Multiple Myeloma.

Name: Mechanisms of NK Cell Activation and Clinical Activity of the Therapeutic SLAMF7 Antibody, Elotuzumab in Multiple Myeloma.
Author: Campbell, Kerry S

Mechanisms of NK Cell Activation and Clinical Activity of the Therapeutic SLAMF7 Antibody, Elotuzumab in Multiple Myeloma. — المؤلف: Campbell, Kerry S — Frontiers in immunology 20190926

المؤلف: Campbell, Kerry S
النشر: Frontiers in immunology 20190926
الوصف: 2551 p.
الموضوعات: Animals؛ Antibodies, Monoclonal, Humanized؛ Antineoplastic Agents؛ Antineoplastic Combined Chemotherapy Protocols؛ Biomarkers, Tumor؛ Dexamethasone؛ GPI-Linked Proteins؛ Humans